AXAxinet
Menu
Finance

Live market screen

Commercial Space Company Risk / Opportunity Ranking

Opportunity/risk view across launch, satellites, SAR, earth observation, defense demand, financing events, and execution risk.

Updated June 27, 2026

Companies analyzed
438
Ranked rows
876
Evidence links
356
Rows per page
20

Opportunity view

Showing rows 181-200 of 438; 20 rows per page.

Sorted by raw opportunity score
RankCompanyScoreThesis / Evidence
181
Earth Eye Co
lowweak
Opp 2
Risk 3

Thesis: The reviewed sources only indicates Earth Eye Co is a Chinese private company associated with the TEE-01B surveillance satellite used for imaging and surveillance. This suggests some asset relevance in Earth observation, but there is no direct business traction or positive catalyst evidence available.

Why now: Why now is weak because there are no available post-recent evidence window evidence, no article summaries, and no clear near- or long-horizon catalyst beyond generic association with a surveillance satellite.

Caveats: Membership rationale cites article IDs and, but the reviewed sources provide no. Company is private and evidence coverage inside the recent evidence window is empty.

182
Exquadrum, Inc.
lowweak
Opp 2
Risk 2

Thesis: The reviewed sources rationale describes Exquadrum as a rocket-maker acquired by Mach Industries, which at least indicates strategic relevance to launch/propulsion capabilities if the acquisition meaningfully advances commercialization (: no provided in reviewed sources).

Why now: No retained evidence establishes current milestone timing or post-acquisition integration progress, so there is no strong why-now supported in these reviewed sources.

Caveats: No current evidence is provided for the cited support article in the reviewed sources. Coverage debug shows articles after recent evidence window = 0 and evidence after recent evidence window = 0. Acquisition context is weaker than direct operating evidence.

183
Fergani Space
lowweak
Opp 2
Risk 2

Thesis: Reviewed evidence rationale suggests Fergani Space launched a fifth test satellite into LEO with communications and navigation capabilities, which could indicate technical progress if still current, but no direct post-recent evidence window evidence are available to support a durable 1 year+ opportunity thesis.

Why now: There is no credible 'why now' catalyst in the reviewed sources because articles after recent evidence window and evidence after recent evidence window are both zero for this company. The only cited support is older or excluded from the active evidence set: article, referenced in the membership rationale, was outside the kept recent evidence window according to the company coverage report.

Caveats: No evidence were available after recent evidence filtering. No representative articles or additional_company_articles were provided. Membership rationale is weaker than direct event/fact evidence.

184
Filtronic PLC
lowweak
Opp 2
Risk 1

Thesis: Older reviewed sources context says Filtronic is in a space/satellite communications context and has a SpaceX deal via article, which could be positive if current, but there is no retained in-window direct positive evidence with to justify a stronger ranking.

Why now: There is no evidenced near-term or durable why-now catalyst inside the retained 90-day evidence window.

Caveats: Reviewed evidence references but provides no representative article. Potentially positive older context may be stale or superseded; recency cannot be validated. No retained evidence after recent evidence window.

185
GalaxEye Space
lowweak
Opp 2
Risk 2

Thesis: The reviewed sources membership rationale describes GalaxEye as launching Mission Drishti, an OptoSAR satellite with defense and disaster-response use cases, which is strategically interesting, but no within the recent evidence window direct evidence is available to support a stronger ranked opportunity.

Why now: There is no within the recent evidence window evidence available in these reviewed sources for GalaxEye Space; timing and maturity of current milestones cannot be confirmed from reviewed sources evidence.

Caveats: Membership rationale cites article IDs and, but their article content is not provided here for citation. Evidence recent evidence review shows 0 kept rows. This entity may overlap with GalaxEye Space Solutions Private Ltd, but the output contract requires scoring both separately.

186
GALVANY
lowweak
Opp 2
Risk 2

Thesis: The membership rationale says GALVANY raised a €10M seed in a European tech funding roundup, which is at least a financing signal that could support future execution. However, the reviewed sources explicitly says funding alone is insufficient without a clear space linkage, and there are no available direct evidence after recent evidence window.

Why now: The only possible timing angle is the referenced seed raise in the membership rationale, but no -backed available evidence remains after the recent evidence filter, so recency and impact cannot be validated for scoring.

Caveats: Membership rationale references article ID: but no is provided in the reviewed sources, so it cannot be cited as factual scoring evidence under the the evidence standard. Funding context does not prove target-cohort fit.

187
GEOST
lowweak
Opp 2
Risk 2

Thesis: GEOST may retain strategic relevance through its cited prototype development role in space domain awareness and the note that it is now Rocket Lab Optical Systems after acquisition, but the reviewed sources provide no retained recent evidence window-window evidence to support a current standalone upside thesis.

Why now: There is no retained within the recent evidence window evidence. Any thesis would rely on older context referenced in the membership rationale, which is insufficient for a stronger rank.

Caveats: Reviewed evidence references acquired-business context rather than current standalone operations. No representative articles or retained evidence are included. Low scores reflect missing timely evidence, not a directional call on the business.

188
GHGSat
lowweak
Opp 2
Risk 2

Thesis: GHGSat likely has strategic relevance as a commercial greenhouse-gas monitoring satellite company, but the reviewed sources includes no available dated evidence to support a stronger opportunity ranking.

Why now: The reviewed sources offers no recent evidence window-supported event timing for a why-now view.

Caveats: The membership rationale says GHGSat is the world's leading commercial greenhouse gas monitoring satellite company, but the supporting article content is not available here for ranking use. Absence of negative evidence is not positive evidence.

189
Globalstar
lowweak
Opp 2
Risk 2

Thesis: Globalstar is described in membership rationale as a satellite communications and direct-to-device company, but the reviewed sources includes no available within the recent evidence window positive evidence to support a stronger ranked opportunity view.

Why now: No within the recent evidence window evidence were available for Globalstar in these reviewed sources, so there is no current catalyst basis to elevate either opportunity or risk.

Caveats: Evidence recent evidence review shows 0 kept rows after the 90-day cutoff. Membership rationale cites article IDs, and: but those article contents are not provided here for direct factual citation. Public company status does not improve ranking without directional evidence.

190
Guoxing Aerospace Technology
lowweak
Opp 2
Risk 2

Thesis: The reviewed sources rationale says Tencent partners with Guoxing Aerospace for Star Computing AI cloud in an article about space-based AI computing, which could imply exposure to a longer-horizon emerging segment if substantiated by direct evidence (: no provided in reviewed sources).

Why now: Space-based AI computing could be strategically relevant over 1 year+, but the reviewed sources provide no retained dated evidence to confirm partnership scope, timing, or commercial milestones.

Caveats: No current evidence is provided for the cited support article in the reviewed sources. Coverage debug shows articles after recent evidence window = 0 and evidence after recent evidence window = 0. Partnership mention alone is insufficient to prove durable company impact.

191
HawkEye 360, Inc.
lowweak
Opp 2
Risk 1

Thesis: The reviewed sources membership rationale says HawkEye 360 provides RF intelligence/data services and has government-linked business, which could support a durable demand thesis, but no within the recent evidence window evidence or article summaries are available to justify a stronger score.

Why now: There is no available post-recent evidence window evidence in the reviewed sources to establish a current catalyst or changed business state.

Caveats: No evidence available after recent evidence window. Cannot rely on membership rationale alone for direction.

192
HawkEye 360, Inc.
lowweak
Opp 2
Risk 2

Thesis: The reviewed sources indicates HawkEye 360 is a space intelligence company with a satellite constellation and government-contract exposure, which could be attractive over a multi-year horizon if contract flow and constellation utilization continue.

Why now: The only retained dated item is an April 5, 2026 supporting article context entry stating HawkEye 360 is a data analytics company developing space-based radio frequency mapping and a satellite constellation startup: That is too weak to establish a strong current catalyst.

Caveats: Only weak supporting article context is retained after recent evidence window; no direct event/fact evidence is available. Phase2 rationale mentions 30+ satellites and government contracts, but the reviewed sources does not provide those source articles in detail here.

193
Innoseis
lowweak
Opp 2
Risk 1

Thesis: Innoseis has the strongest limited positive context in this screen because the membership rationale says it raised €6M and has applications in space exploration, with technology selected for future Moon measurements, which could support a long-horizon opportunity if substantiated by direct evidence (: unavailable in reviewed sources). However, the reviewed sources have no direct positive evidence within the recent evidence window, so the thesis remains low confidence.

Why now: Potentially relevant because the article context references funding and lunar-measurement selection, but the reviewed sources provide no dated evidence or, so recency and sequence cannot be verified beyond the membership rationale tied to

Caveats: No current evidence is provided for cited Zero evidence available after recent evidence window despite the membership rationale. Funding and technology-selection references are article-context level only here.

194
Intelsat
lowweak
Opp 2
Risk 1

Thesis: The only positive indication in the reviewed sources are membership rationale stating Intelsat participated with Viasat in a Space Force mini-GEO satellite award, which could support a long-horizon government satcom opportunity if current and material, but no direct evidence or article summaries are available after the 90-day recent evidence window.

Why now: Why now is weak because coverage data shows 0 article IDs after recent evidence window and 0 evidence available after recent evidence window, so timing and durability cannot be validated from these reviewed sources.

Caveats: Membership rationale cites article IDs: and: but the reviewed sources provide no or summaries for them. Evidence recent evidence review shows kept_rows 0 and undated_rows_kept 0, so there is no usable direct evidence inside the ranking window. Cannot treat cohort membership as thesis attractiveness.

195
Intelsat General
lowweak
Opp 2
Risk 2

Thesis: Reviewed evidence membership rationale says Intelsat General was tied to a Space Force PTS-G satellite contract, which could support long-horizon defense-space opportunity, but no post-recent evidence window evidence or article summaries were available for scoring.

Why now: Why-now support is weak because coverage data shows zero article/evidence after the 90-day recent evidence window, so recency for the cited contract context cannot be validated from available evidence.

Caveats: Phase2 membership rationale references: but no representative article or evidence row is available after recent evidence window for direct citation. Coverage data reports articles after recent evidence window = 0 and evidence after recent evidence window = 0. Scored low due to evidence absence, not due to negative business evidence.

196
iQPS
lowweak
Opp 2
Risk 1

Thesis: Membership rationale says Rocket Lab secured a multi-launch agreement with iQPS for SAR satellites, which suggests iQPS may have meaningful constellation deployment activity over a 1 year+ horizon if current.

Why now: Why now is limited because the support is only referenced through membership rationale citing articles and, but the reviewed sources provide no or retained evidence after recent evidence window.

Caveats: No or article summaries are provided for cited support articles and. Coverage data shows zero retained evidence after recent evidence window. Potentially interesting launch-agreement signal cannot be scored highly without direct reviewed sources evidence.

197
Jacobs
lowweak
Opp 2
Risk 2

Thesis: Jacobs has evidence of a large Space Force Range Contract award worth up to $4 billion over 10 years, which would ordinarily support a positive thesis, but the relevant articles are dated June 3, 2025 and are outside the reviewed sources' 90-day recent evidence window, so current opportunity support is weak in these reviewed sources.

Why now: Why now is weak because the contract evidence is older. The reviewed sources cites Space Force and SpaceNews articles dated June 3, 2025, which are outside the 90-day evidence window

Caveats: Contract evidence exists but falls outside the selected 90-day recent evidence window. No direct positive or negative evidence remain after recent evidence filtering.

198
Jio Platforms
lowweak
Opp 2
Risk 2

Thesis: The reviewed sources rationale says Jio Platforms is the vehicle for Reliance's planned multi-billion-dollar LEO satellite communications entry and planned network to compete with Starlink and Kuiper, which suggests long-horizon optionality if execution proceeds, but no underlying article evidence is provided in these reviewed sources output.

Why now: Why now is not well supported in the served evidence because no representative articles or direct evidence are available after recent evidence window despite the membership rationale referencing article IDs, and

Caveats: No representative articles or direct evidence are included in the reviewed sources output. Membership rationale is not a substitute for direct thesis evidence. Recency and event sequence cannot be judged from the missing article details.

199
Karman Holdings Inc.
lowweak
Opp 2
Risk 1

Thesis: Karman Holdings has modest contextual upside because the membership rationale says the reviewed sources placed it in broad space/defense and supply-chain articles and provided revenue facts, which may indicate operating scale or relevance to a durable strategic cycle, unavailable in reviewed sources). But there is no available direct positive evidence after recent evidence window, so this does not support more than a low opportunity score.

Why now: Why now is weak because there are no retained evidence after the 90-day cutoff date of March 29, 2026, despite multiple older considered articles.

Caveats: No current evidence is provided for and. Revenue facts are referenced only in the membership rationale, not available as direct evidence. Broad supply-chain context is weaker than company-specific contract or product evidence.

200
Korea Aerospace Industries (KAI)
lowweak
Opp 2
Risk 2

Thesis: Limited opportunity based only on the reviewed sources membership rationale that identifies CAS500-2 as an Earth observation satellite for KAI, indicating confirmed participation in a qualifying satellite activity but not providing a new catalyst, contract, backlog, or financial inflection.

Why now: Why now is weak because the reviewed sources say one article supported membership, article ID: but no, timing detail, or direct evidence were available after recent evidence window.

Caveats: No direct evidence or article summaries were available after recent evidence window. Membership support references article ID: without a in the reviewed sources.

Risk view

Showing rows 281-300 of 438; 20 rows per page.

Sorted by raw risk score
RankCompanyScoreThesis / Evidence
281
COMSAT
lowweak
Opp 0
Risk 1

Thesis: No material adverse thesis is supported either. The reviewed sources only provides thin acquisition-context mention, so risk remains low-scored for lack of evidence rather than comfort.

Why now: No 90-day article summaries or evidence were available for COMSAT in these reviewed sources, so there is no supported timing catalyst.

Caveats: Relations/context-only style mention should not be used as counterparty propagation evidence. Phase2 rationale references article ids: and: but no or summaries are provided in the reviewed sources. No direct evidence were available after recent evidence window.

282
Comtech Telecommunications Corp.
lowweak
Opp 1
Risk 1

Thesis: No material adverse thesis can be supported from these reviewed sources because no direct negative evidence are provided within the recent evidence window.

Why now: There is no usable company-specific evidence in the reviewed sources after recent evidence filtering; coverage data shows zero article IDs after recent evidence window and zero evidence available, so there is no current catalyst basis in these reviewed sources.

Caveats: Absence of evidence is not positive evidence. Reviewed evidence notes only weak peer-group context in phase2 rationale, but no citable article details are included in the scoring fields.

283
Cosmoserve
lowweak
Opp 1
Risk 1

Thesis: No material adverse company-specific evidence is provided. The primary risk is simply that the evidence is too indirect to support a real thesis.

Why now: No in-recent evidence window article summary or evidence row was available for Cosmoserve, so there is no supported catalyst timing.

Caveats: The mention is article-level and indirect rather than company-specific. Phase2 rationale references article id: but no or summary is included. No direct evidence were available after recent evidence window.

284
Cosmoserve Space
lowweak
Opp 1
Risk 1

Thesis: No retained 90-day negative evidence supports a risk thesis.

Why now: The reviewed sources retains zero evidence after the recent evidence filter, leaving no current catalyst or recency-supported business update.

Caveats: Only one historical article was considered and none are retained within the recent evidence window. The single membership support item is not enough for a current directional call. This is effectively a watchlist placeholder until newer evidence appears.

285
Curtiss-Wright Corporation
lowweak
Opp 2
Risk 1

Thesis: No material adverse evidence is available. The main risk is evidentiary weakness: supplier-beneficiary framing without direct contract, backlog, or financial evidence leaves the thesis unproven.

Why now: Potentially relevant if broader space spending is increasing, but the reviewed sources provide no retained dated evidence, no current data, so timing and magnitude cannot be validated.

Caveats: No current evidence is provided for Relation/context evidence must not be used as counterparty propagation; reviewed sources notes context only. No available direct evidence after recent evidence window despite high article count considered.

286
Deloitte
lowweak
Opp 2
Risk 1

Thesis: No material negative evidence is retained in the reviewed sources.

Why now: The reviewed sources rationale says Deloitte launched satellites for Project Constellation to test on-orbit cyber protections and contracted Spire to design, build, and operate satellites, citing article, but no or retained evidence row is available after recent evidence window, limiting confidence.

Caveats: The described activity comes only from membership rationale rather than retained evidence. Without retained dated evidence or, chronology and durability cannot be tested.

287
Digantara
lowweak
Opp 1
Risk 1

Thesis: No retained 90-day negative evidence supports a material risk call.

Why now: Despite several historical mentions, the reviewed sources show zero retained article IDs and zero evidence after recent evidence filtering, so there is no recent catalyst evidence in the served data.

Caveats: Historical support mentions approximately $50M funding, but the underlying evidence is not retained within the current recent evidence window reviewed sources. Low scores reflect missing current evidence, not a negative operating judgment.

288
Digantara
lowweak
Opp 1
Risk 1

Thesis: No direct adverse evidence is provided in the reviewed sources. The main issue is lack of current evidence within the recent evidence window, so risk cannot be ranked highly.

Why now: There is no strong 'why now' because coverage data shows zero article IDs after recent evidence window and zero evidence after recent evidence window, so any thesis would be under-supported for current timing.

Caveats: No evidence remained after the 90-day recent evidence window. Phase-2 membership rationale is not enough for a directional thesis by itself. Recency and business-state claims are unavailable in the reviewed sources.

289
DPhi Space
lowweak
Opp 1
Risk 1

Thesis: No material adverse thesis is supported. The main issue is lack of substantiated company-specific evidence.

Why now: No available article summaries or evidence exist after recent evidence window for DPhi Space in these reviewed sources, so there is no supported why-now catalyst.

Caveats: Support level is only provisional_single_article_context in the reviewed sources. Phase2 rationale references article id, but no or summary is included. No evidence were available after recent evidence window.

290
Elbit Systems Ltd.
lowweak
Opp 1
Risk 1

Thesis: Despite broad defense and geopolitical exposure implied by context, the reviewed sources have no direct negative evidence within the recent evidence window, so no adverse thesis is supportable.

Why now: Membership rationale references articles: and, but coverage data shows articles after recent evidence window = 0 and evidence after recent evidence window = 0. unavailable in reviewed sources.

Caveats: Large mention volume is not conviction. Defense-space context is not directional proof. Referenced have no in the reviewed sources.

291
Element U.S. Space & Defense
lowweak
Opp 0
Risk 1

Thesis: No direct adverse evidence is retained, but the company is especially thinly covered in these reviewed sources, which raises uncertainty rather than a demonstrable risk case.

Why now: Why now is absent because only 2 articles were considered and none survived the 90-day filter; there is no current evidence basis for a 1 year+ directional call.

Caveats: Coverage is extremely sparse. The only described relation is context/service oriented and relations are context-only unless policy-gated. No post-cutoff evidence available.

292
Emposat
lowweak
Opp 1
Risk 1

Thesis: No material adverse evidence is available within the reviewed sources' recent evidence window.

Why now: There is no available within the recent evidence window evidence row after the March 29, 2026 cutoff; coverage data shows zero article IDs after recent evidence window and zero evidence after recent evidence window for Emposat.

Caveats: Phase-2 membership rationale references articles and, but the reviewed sources provide no for citation. Ground-station context is indirect and not enough for a strong thesis under the evidence standard.

293
EnduroSat
lowweak
Opp 1
Risk 1

Thesis: No material adverse evidence is provided in the reviewed sources after recent evidence filtering, so a negative thesis is unsupported.

Why now: Why now is unsupported because no evidence remain after recent evidence filtering; there is no dated catalyst, financing, contract, production, or customer evidence available here.

Caveats: No surviving evidence after recent evidence filtering. Reviewed evidence counts indicate evidence existed upstream, but none is included here for direct citation. Low scores reflect missing evidence, not a fundamental negative judgment.

294
Filtronic PLC
lowweak
Opp 2
Risk 1

Thesis: No material adverse thesis is supported because no direct negative evidence is retained in the reviewed sources.

Why now: There is no evidenced near-term or durable why-now catalyst inside the retained 90-day evidence window.

Caveats: Reviewed evidence references but provides no representative article. Potentially positive older context may be stale or superseded; recency cannot be validated. No retained evidence after recent evidence window.

295
FOSSA Systems
lowweak
Opp 1
Risk 1

Thesis: No material adverse evidence is available in the reviewed sources, so there is no supported risk thesis beyond generic startup and execution uncertainty, which is insufficient under the evidence rules.

Why now: No within the recent evidence window evidence are available after filtering, so there is no near-dated trigger or state change that can be scored from the local reviewed sources.

Caveats: Membership support references article, but that article content is not available here for direct citation. Coverage debug shows zero evidence after recent evidence window. A positive thesis requires positive evidence, not just category fit or membership rationale.

296
Fujitsu
lowweak
Opp 3
Risk 1

Thesis: No material negative evidence is available. The main risk is that space may remain too small a contributor within Fujitsu's broader business to drive a distinct thesis, but this is an inference from the reviewed sources' boundary ambiguity rather than direct adverse evidence (: and; not provided in reviewed sources).

Why now: An MOU in SDA could matter over a 1 year+ horizon if it converts into deployments or service revenue, but the reviewed sources offers no direct dated evidence inside recent evidence window and no article to validate timing.

Caveats: Large diversified company; reviewed sources does not show materiality of space effort. MOU is weaker than signed commercial contract revenue evidence. No direct article content or is available in reviewed sources.

297
GE Aerospace
lowweak
Opp 1
Risk 1

Thesis: No reviewed sources-supported adverse thesis is available. There is also no material direct negative evidence after the 90-day recent evidence window.

Why now: There is no current catalyst in the reviewed sources. Coverage shows 32 article IDs considered but zero article IDs after recent evidence window and zero evidence after recent evidence window, so recency-based ranking is not supported.

Caveats: Phase2 rationale says only generic stock-screener style article context was available, citing article IDs, and, but no were provided in the reviewed sources. Evidence recent evidence review shows no current evidence was retained and undated_rows_kept = 0. Without for the cited membership-support articles, they cannot be used as factual thesis evidence under the citation requirement.

298
Gilat Satellite Networks Ltd.
lowweak
Opp 1
Risk 1

Thesis: Insufficient retained local evidence within the 90-day recent evidence window to support a material adverse thesis.

Why now: No company-specific dated evidence were retained after the 90-day recent evidence window cutoff of March 29, 2026, so there is no current catalyst basis in the reviewed sources.

Caveats: Reviewed evidence shows 64 articles considered but 0 article IDs after recent evidence window and 0 evidence retained. Membership support cited article IDs: and: but no article summaries or retained evidence are provided in these reviewed sources, so no factual thesis claims can be grounded from them.

299
GS Yuasa Corporation
lowweak
Opp 3
Risk 1

Thesis: No material adverse evidence is retained. The main limitation is that the reviewed sources does not prove the scale, growth, or competitiveness of GS Yuasa's space exposure.

Why now: There is no verified near-term catalyst, but the reviewed sources' phase-2 rationale references saying GS Yuasa was named as a key player in a space battery market report. Without, timing detail, or retained evidence, recency is uncertain.

Caveats: The rationale cites, but no or retained article text is provided. Being listed as a key player in a market report is weaker than direct contract, launch, or financial evidence. No retained evidence remain after the 90-day recent evidence window.

300
HawkEye 360, Inc.
lowweak
Opp 2
Risk 1

Thesis: Government concentration or defense-program dependence could be a risk, but the reviewed sources contain no direct negative evidence within the available recent evidence window.

Why now: There is no available post-recent evidence window evidence in the reviewed sources to establish a current catalyst or changed business state.

Caveats: No evidence available after recent evidence window. Cannot rely on membership rationale alone for direction.